Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: June 2014

2013 – SSRI exposure increases risk for spontaneous abortion

Posted in SSRI Birth Defects

Published in the August 2013 of PLoS One, a piece by medical researchers from Denmark titled “Prenatal antidepressant exposure and risk of spontaneous abortion – a population-based study.” lives up to its title and presents information regarding the rate for spontaneous abortion with prenatal exposure to antidepressants gathered via a large, retrospective study. The team,… Continue Reading

2005 – Adverse birth outcomes linked to prenatal SSRI exposure

Posted in Prozac Birth Defects, SSRI Birth Defects

In 2005, T.F. Oberlander et al. published results of a study titled “Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.” in the medical journal Pediatrics, demonstrating further the risks of prenatal exposure to selective serotonin reuptake inhibitor drugs, or “SSRIs.” The team writes “In this prospective study, we examined… Continue Reading

Medical professionals link Lipitor to new onset diabetes

Posted in Lipitor

In recent years, a great deal of research has been published linking Lipitor (atorvastatin) use and new onset diabetes.  Unfortunately, Lipitor warning labels have inadequately represented these risks, and a number of Lipitor diabetes lawsuits have been filed.  Lipitor (atorvastatin) is in a class of cholesterol-lowering drugs called “statins,” and are among the world’s most… Continue Reading

Three more studies illustrate risks of Prozac during pregnancy

Posted in Prozac Birth Defects, SSRI Birth Defects

This morning, I found three more studies discussing the risks of prenatal Prozac exposure.  One  discuses long-term effects, one describes behavioral effects, and another describes birth defects “caused” by Prozac.  For other studies on the risks of Prozac exposure during pregnancy, follow the preceding link. A team of researchers led by V. Kiryanova (2013) published… Continue Reading

2007 – Birth defects seen in rats exposed to Prozac

Posted in Prozac Birth Defects, SSRI Birth Defects

Today, I came across a 2007 study linking adverse birth outcomes with exposure to Prozac (fluoxetine) during pregnancy.  This article, by E. Fornaro et al., a team of Canadian medical researchers, titled “Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat.” published in American Journal of Respiratory and Critical Care Medicine links persistent… Continue Reading

2012 – Prozac exposure and adverse effects on baby rats, including low birth weight

Posted in Prozac Birth Defects, SSRI Birth Defects

In 2012, an article by B.B. McAllister et al. published in Neuroscience titled “Behavioural outcomes of perinatal maternal fluoxetine treatment.” further illustrates the risks tied to prenatal fluoxetine (Prozac) exposure, demonstrating resulting developmental issues in gestational mice. The team writes “During and following pregnancy, women are at considerable risk of experiencing depression. For treatment, selective… Continue Reading

More research links Lipitor and diabetes

Posted in Lipitor

In recent years, a number of scientific studies have been published linking the use of statin drugs to new onset diabetes.  Examples of these drugs include Lipitor, Crestor, Zocor, and others; and though the cardiovascular benefits of these drugs are not to be discounted, patients ought to be aware of all possible risks.  Here are… Continue Reading

2009 – Research shows SSRIs cross placenta

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Published in May, 2009 in Pharmacopsychiatry by a team of Australian researchers led by J. Rampono, an article titled “Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.” provides further evidence that drugs such as Celexa, Lexapro, Prozac, Paxil, Zoloft, Effexor and others may cross the placenta and affect a developing fetus…. Continue Reading

Three more studies link Celexa, SSRIs to adverse birth outcomes

Posted in Celexa Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Over the past several decades, a number of studies have linked Celexa exposure and birth defects.  This morning, I found several more, some of which are summarized below.  For more articles demonstrating the connection between birth defects and Celexa, follow the preceding link. In a 2013 edition of Fetal and Pediatric Pathology, an article by… Continue Reading

2006 – Developmental problems linked to Celexa exposure in pregnancy

Posted in Celexa Birth Defects, SSRI Birth Defects

In a 2006 edition of Neuropsychopharmacology, an article by D. Maciag et al. titled “Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.” provides important insight into the risks of neonatal exposure to selective serotonin reuptake inhibitor drugs before birth. The team writes “A significant fraction of infants born to mothers taking selective… Continue Reading

2008 – Prozac linked to perinatal complications

Posted in Prozac Birth Defects, SSRI Birth Defects

In December, 2008, a team of researchers from the Baskent University Faculty of Medicine, in Ankara, Turkey, led by F. Alehan, published a study titled “Prolonged neonatal complications after in utero exposure to fluoxetine.” in The Journal of Maternal-Fetal and Neonatal Medicine.  This article provided further evidence that prenatal exposure to selective serotonin reuptake inhibitor… Continue Reading